Similar Posts
Tides Express | Novogene’s HPV therapeutic DNA nucleic acid drug achieves breakthrough progress in Phase I clinical trials
On August 20, 2024, the content team of Sinopharm Biopharmaceuticals announced that NWRD08, an HPV therapeutic nucleic acid drug independently developed by Novobio, has made breakthrough progress in its registered clinical phase I project at Peking Union Medical College Hospital. The first subject – a patient with HPV16 positive infection and recurrent HSIL (high-grade squamous…